Biotech Archives - Page 671 of 733

1 minute read

Sanofi-Regeneron’s Flagship Drug Shows Consistent Efficacy, Safety Profile At Two Years For Asthma In Kids

September 6, 7:10 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (NASDAQ:SNY) announced results from a Phase 3 open-label extension trial of Dupixent (dupilumab) as maintenance therapy…

REGN

2 minute read

Avalo Advances BTLA Agonist Fusion Protein (AVTX-008) To IND-enabling Stage

By Bill Haddad

September 6, 7:09 AM

Avalo Therapeutics, Inc. (NASDAQ:AVTX) announced today that its human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein, AVTX-008, has now entered IND-enabling studies, with a target IND submission date of

AVTX

1 minute read

Allena Pharmaceuticals Shares Fall After Filing For Bankruptcy

By Vandana Singh

September 6, 7:06 AM

In its SEC filing, Allena Pharmaceuticals Inc (NASDAQ:ALNA) filed for chapter 11 bankruptcy protection and terminated the employment of substantially…

ALNA

4 minute read

Ironwood Pharmaceuticals Reports Positive Topline Data From Phase III Trial Of LINZESS (linaclotide) In Pediatric Patients Aged 6-17 With Functional Constipation; Study Met Primary And Secondary Endpoints

By Bill Haddad

September 6, 7:04 AM

– Study met primary and secondary endpoints – – Results add to body of data supporting the safety of linaclotide for this patient population – – There are currently no FDA approved

IRWD

3 minute read

Mannkind Completes Phase 1 Study of Inhaled Clofazimine; Says ‘Study supports the dosing regimen that will be pursued in further clinical programs’

By Bill Haddad

September 6, 6:15 AM

Study supports the dosing regimen that will be pursued in further clinical programs No serious adverse events or QT prolongation identified Planning underway to discuss results and the ongoing clinical

MNKD

1 minute read

IDEAYA Announces First-Patient-In for Phase I Clinical Trial to Evaluate Darovasertib Monotherapy in (Neo)Adjuvant Uveal Melanoma

By Bill Haddad

September 6, 6:04 AM

- Investigator Sponsored Trial sites in Australia include St. Vincent's Hospital, Sydney, Alfred Health, Melbourne, and the Royal Victorian Eye and Ear Hospital, Melbourne - Preliminary signals of clinical activity

IDYA

1 minute read

SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile

By Bill Haddad

September 6, 6:01 AM

Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced that the Chilean Public Health Institute (Instituto de Salud

SVA